GB201204457D0 - Polypeptides and their use - Google Patents

Polypeptides and their use

Info

Publication number
GB201204457D0
GB201204457D0 GBGB1204457.4A GB201204457A GB201204457D0 GB 201204457 D0 GB201204457 D0 GB 201204457D0 GB 201204457 A GB201204457 A GB 201204457A GB 201204457 D0 GB201204457 D0 GB 201204457D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1204457.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NovaBiotics Ltd
Original Assignee
NovaBiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NovaBiotics Ltd filed Critical NovaBiotics Ltd
Priority to GBGB1204457.4A priority Critical patent/GB201204457D0/en
Publication of GB201204457D0 publication Critical patent/GB201204457D0/en
Priority to NZ700467A priority patent/NZ700467A/en
Priority to HK15101528.2A priority patent/HK1201050A1/xx
Priority to KR1020147028818A priority patent/KR20140138940A/ko
Priority to MX2014010996A priority patent/MX2014010996A/es
Priority to EP13718609.4A priority patent/EP2825261A1/en
Priority to AU2013234122A priority patent/AU2013234122A1/en
Priority to PCT/GB2013/000112 priority patent/WO2013136040A1/en
Priority to CA2866837A priority patent/CA2866837A1/en
Priority to RU2014139857A priority patent/RU2014139857A/ru
Priority to JP2014561504A priority patent/JP2015516943A/ja
Priority to CN201380014410.5A priority patent/CN104428036A/zh
Priority to SG11201405539QA priority patent/SG11201405539QA/en
Priority to US14/004,344 priority patent/US20140155321A1/en
Priority to CL2014002397A priority patent/CL2014002397A1/es
Priority to IL234646A priority patent/IL234646A0/en
Priority to ZA2014/07276A priority patent/ZA201407276B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
  • Cosmetics (AREA)
GBGB1204457.4A 2012-03-14 2012-03-14 Polypeptides and their use Ceased GB201204457D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB1204457.4A GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use
US14/004,344 US20140155321A1 (en) 2012-03-14 2013-03-14 Polypeptides and Their Use
CA2866837A CA2866837A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use
JP2014561504A JP2015516943A (ja) 2012-03-14 2013-03-14 ポリペプチド及びその使用
KR1020147028818A KR20140138940A (ko) 2012-03-14 2013-03-14 폴리펩티드 및 그 용도
MX2014010996A MX2014010996A (es) 2012-03-14 2013-03-14 Polipeptidos y su uso.
EP13718609.4A EP2825261A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use
AU2013234122A AU2013234122A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use
PCT/GB2013/000112 WO2013136040A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use
NZ700467A NZ700467A (en) 2012-03-14 2013-03-14 Treatments suitable for malassezia infections
RU2014139857A RU2014139857A (ru) 2012-03-14 2013-03-14 Полипептиды и их применение
HK15101528.2A HK1201050A1 (en) 2012-03-14 2013-03-14 Polypeptides and their use
CN201380014410.5A CN104428036A (zh) 2012-03-14 2013-03-14 多肽及其用途
SG11201405539QA SG11201405539QA (en) 2012-03-14 2013-03-14 Polypeptides and their use
CL2014002397A CL2014002397A1 (es) 2012-03-14 2014-09-10 Polipeptidos para usarse en el tratamiento y/o prevención de una infección fúngica ocasionada por malassezia spp.
IL234646A IL234646A0 (en) 2012-03-14 2014-09-14 Peptides and their use
ZA2014/07276A ZA201407276B (en) 2012-03-14 2014-10-07 Polypeptides and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1204457.4A GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use

Publications (1)

Publication Number Publication Date
GB201204457D0 true GB201204457D0 (en) 2012-04-25

Family

ID=46026493

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1204457.4A Ceased GB201204457D0 (en) 2012-03-14 2012-03-14 Polypeptides and their use

Country Status (17)

Country Link
US (1) US20140155321A1 (https=)
EP (1) EP2825261A1 (https=)
JP (1) JP2015516943A (https=)
KR (1) KR20140138940A (https=)
CN (1) CN104428036A (https=)
AU (1) AU2013234122A1 (https=)
CA (1) CA2866837A1 (https=)
CL (1) CL2014002397A1 (https=)
GB (1) GB201204457D0 (https=)
HK (1) HK1201050A1 (https=)
IL (1) IL234646A0 (https=)
MX (1) MX2014010996A (https=)
NZ (1) NZ700467A (https=)
RU (1) RU2014139857A (https=)
SG (1) SG11201405539QA (https=)
WO (1) WO2013136040A1 (https=)
ZA (1) ZA201407276B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016244073B2 (en) * 2015-04-03 2019-02-28 Elc Management Llc Hair treatment compositions
JP6553961B2 (ja) * 2015-06-25 2019-07-31 花王株式会社 美白剤
WO2017047299A1 (ja) * 2015-09-15 2017-03-23 富士フイルム株式会社 注射用液剤組成物
CN109700834A (zh) * 2019-01-18 2019-05-03 上海市农业科学院 一种蛹虫草固体发酵物及其抗菌用途
AR122485A1 (es) * 2020-06-04 2022-09-14 Syngenta Crop Protection Ag Composiciones fungicidas
CN115381928B (zh) * 2022-10-27 2022-12-27 山东中医药大学附属医院 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1927597B1 (en) * 2004-08-18 2016-11-02 Novabiotics Limited Antibacterial peptides
GB0611115D0 (en) * 2006-06-06 2006-07-19 Novabiotics Ltd Compounds and their use
GB0702022D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
RU2491052C2 (ru) * 2007-12-21 2013-08-27 Басф Се Противоперхотные композиции, содержащие пептиды

Also Published As

Publication number Publication date
NZ700467A (en) 2016-08-26
US20140155321A1 (en) 2014-06-05
IL234646A0 (en) 2014-11-30
ZA201407276B (en) 2015-06-24
MX2014010996A (es) 2014-10-13
EP2825261A1 (en) 2015-01-21
AU2013234122A1 (en) 2014-10-16
CN104428036A (zh) 2015-03-18
CA2866837A1 (en) 2013-09-19
CL2014002397A1 (es) 2015-02-27
JP2015516943A (ja) 2015-06-18
HK1201050A1 (en) 2015-08-21
KR20140138940A (ko) 2014-12-04
WO2013136040A1 (en) 2013-09-19
SG11201405539QA (en) 2014-10-30
RU2014139857A (ru) 2016-05-10

Similar Documents

Publication Publication Date Title
IL291571A (en) cx3cr1 binding polypeptides
IL235826A0 (en) Diazaspirocycloalkane and azaspirocycloalkane
ZA201500097B (en) Modified factor x polypeptides and uses thereof
GB201201100D0 (en) Polypeptides and methods
IL236616B (en) 5-aminotetrahydroquinoline-2-carboxylic acids and their use
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
IL237926A0 (en) Combinations and their uses
SG11201500111VA (en) Peptides and uses thereof
GB201220474D0 (en) Polypeptides
SG11201501646PA (en) Peptides and their uses
SG11201402139UA (en) High mast2-affinity polypeptides and uses thereof
ZA201405392B (en) Substituted phenylimidazopyrazoles and use thereof
PL2855506T3 (pl) Peptydy i ich zastosowanie
EP2825548A4 (en) MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF
ZA201407276B (en) Polypeptides and their use
EP2820034A4 (en) MODIFIED ADIPONECTINPOLYPEPTIDES AND ITS USES
SG11201504482VA (en) Beta-hexosyl-transferases and uses thereof
ZA201504462B (en) TGFß-DERIVED POLYPEPTIDES AND USES THEREOF
GB201210303D0 (en) Polypeptides and methods
GB201214769D0 (en) Methodsa and peptides
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
GB201215414D0 (en) Composition and use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)